Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Pharmaceutics|June 27, 2024
Population Pharmacokinetics in Oncology and Its Clinical ApplicationsNicolas Widmer, Monia Guidi, Thierry Buclin
Revue Medicale Suisse|September 5, 2008
[Therapeutic drug monitoring: clinical practice]Nicolas Widmer, Dominique Werner, Eric Grouzmann, et al.
Leukemia Research|May 22, 2014
Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditionsVerena Gotta, Stephane Bouchet, Nicolas Widmer, et al.
British Journal of Clinical Pharmacology|August 16, 2012
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumoursAmina Haouala, Nicolas Widmer, Monia Guidi, et al.
Pharmaceutics|April 28, 2023
Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A PerspectiveMyriam Briki, Pascal André, Yann Thoma, et al.
Therapeutic Drug Monitoring|September 24, 2025
Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current ChallengesSandro Carrara, Nicolas Widmer, Francesca Rodino, et al.
Revue Medicale Suisse|September 5, 2008
[Pharmacogenetic testing: soon before every prescription?]Thierry Buclin, Sara Colombo, Jérôme Biollaz
The Journal of Antimicrobial Chemotherapy|September 9, 2021
Long-acting antiretrovirals: a new era for the management and prevention of HIV infectionPaul Thoueille, Eva Choong, Matthias Cavassini, et al.
Therapeutic Drug Monitoring|March 19, 2013
Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomesVerena Gotta, Thierry Buclin, Chantal Csajka, et al.
Therapeutic Drug Monitoring|May 17, 2014
Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literatureEmilie Petit-Jean, Thierry Buclin, Monia Guidi, et al.
Pageof 34